Advertisement

Spinal Tech

The Food and Drug Administration has imposed regulations on using stem cell therapies for orthopedic applications despite studies that suggest these therapies are beneficial, according to a news release from the Association of American Physicians and Surgeons.

DJO Global recently named Michael P. Mogul as the company's new chief executive officer, succeeding Les Cross, according to a company news release.

Advertisement

Stryker purchased an MMP Portfolio license from TPL Group and Patriot Scientific, co-owner of the Moore Microprocessor Patent Portfolio, according to a Patriot Scientific news release.

Integra LifeSciences bought SeaSpine, a spinal fusion device company, for $89 million in cash. The combination of SeaSpine's portfolio with Integra LifeSciences' existing spine business will make its spine and orthobiologics portfolio the largest component of the company.

Advertisement